Lena Miller

Alchem Laboratories (United States) — United States

Medicine · Health Sciences

5h-index308citations8works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(5), HIV Research and Treatment(4), Biochemical and Molecular Research(2), HIV/AIDS Research and Interventions(1), DNA and Nucleic Acid Chemistry(1)

Publications8 total

Creating Middle Ground: Transforming Outdoor Informal Learning Landscapes
Curator The Museum Journal·2022· 2 cited
A Qualitative Evaluation of the Phoenix Project: A Strengths-based, Trauma-Informed Care Intervention for African American, Transitional Age, Young Adults Living in San Francisco’s Public Housing Community
USF Scholarship Repository (University of San Francisco)·2020Open Access
Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase
European Journal of Medicinal Chemistry·2017· 25 citedOpen Access
Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H
Journal of Medicinal Chemistry·2016· 61 citedOpen Access
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations
Journal of Medicinal Chemistry·2016· 42 citedOpen Access
Expanding the Nurse Practitioner Role in Treatment Resistant Major Depression
Journal of Hospital & Medical Management·2016· 3 citedOpen Access
Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities
Journal of Medicinal Chemistry·2014· 132 citedOpen Access
Interaction of HIV‐1 Reverse Transcriptase Ribonuclease H with an Acylhydrazone Inhibitor
Chemical Biology & Drug Design·2010· 43 citedOpen Access

Frequent Co-authors

Michael A. Parniak(5), Stefan G. Sarafianos(4), Zhengqiang Wang(4), Éva Nagy(3), Karen A. Kirby(3), Daniel J. Wilson(3), Sanjeev Kumar V. Vernekar(2), Jayakanth Kankanala(2), Feng Liu(2), Jing Tang(2), Zheng Liu(1), Qingguo Gong(1), Lakshmi Menon(1), Tatiana V. Ilina(1), Jin-Woo Ahn(1), Rieko Ishima(1), Bulan Wu(1), Yue-Lei Chen(1), Andrew D. Huber(1), Nataliya Myshakina(1)